Maine Education Ass'n Benefits Trust v. Cioppa
842 F. Supp. 2d 386
D. Me.
2012

Background

  • MEABT provides a community-rated health insurance plan to ~67,000 members via Anthem, with subsidies varying by district.
  • LD 1326 ( enacted 2011; effective Oct 1, 2011) requires competitive bidding for school plan insurance and disclosure of loss information to districts.
  • MEABT keeps loss information confidential as a trade secret; Anthem and MEABT contracts prohibit disclosure of district-specific loss data.
  • Loss information is defined to include premium receipts, claims paid, and loss ratio, but not health status or medical diagnoses.
  • If LD 1326 is not enjoined, districts will request and obtain loss information, potentially triggering shifts to lower-cost insurers; such defections could take months to years to unfold.
  • Court denies Plaintiffs’ motion for a preliminary injunction; only Count II (Unlawful Taking) remains; the court finds no substantial likelihood of success or irreparable harm sufficient to warrant relief.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Likelihood of success on Count II (taking) MEABT contends LD 1326 takes its loss data trade secrets LD 1326 regulates insurance disclosure to promote competition Unlikely; Penn Central factors not satisfied for a taking
Irreparable harm Disclosure will cause immediate, irreparable loss of trade secrets Potential economic impact is speculative; harm not irreparable Not shown; irreparable harm not established
Balance of harms & public interest Injury from disclosure harms MEABT and districts Regulation serves public interest in competition and choice Public interest favors denial; balance does not justify injunction

Key Cases Cited

  • Iantosca v. Step Plan Servs., Inc., 604 F.3d 24 (1st Cir. 2010) (burden on movant; four-factor test for injunction)
  • Jean v. Mass. State Police, 492 F.3d 24 (1st Cir. 2007) (likelihood of success is the most important factor)
  • Ty, Inc. v. Jones Group, Inc., 237 F.3d 891 (7th Cir. 2001) (sliding scale approach to irreparable harm)
  • Charlesbank Equity Fund II v. Blinds to Go, 370 F.3d 151 (1st Cir. 2004) (irreparable harm must be more than conjecture)
  • Saco Def. Sys. Div., Maremont Corp. v. Weinberger, 606 F.Supp. 446 (D.Me. 1985) (equitable remedy should be used sparingly)
  • Plain Dealer Pub. Co. v. Cleveland Typographical Union No. 53, 520 F.2d 1220 (6th Cir. 1975) (standard guidance for injunctions)
  • New Comm Wireless Servs., Inc. v. SprintCom, Inc., 287 F.3d 1 (1st Cir. 2002) (likelihood of success weighs against irreparable harm)
  • Penn Central Transp. Co. v. New York City, 438 U.S. 104 (1978) (three-factor takings framework)
  • Lingle v. Chevron U.S.A. Inc., 544 U.S. 528 (2005) (per se takings framework not applicable here)
  • Franklin Mem’l Hosp. v. Harvey, 575 F.3d 121 (1st Cir. 2009) (regulatory takings analysis guidance)
  • Monsanto Co. v. Specht, 467 U.S. 1006 (1984) (investment-backed expectations may be tempered in regulated industries)
  • Philip Morris, Inc. v. Reilly, 312 F.3d 24 (1st Cir. 2002) (economic impact analysis in takings context)
  • Garda-Rubiera v. Calderon, 570 F.3d 443 (1st Cir. 2009) (ripeness and takings considerations)
  • Pharm. Care Mgmt. Ass'n v. Rowe, 307 F.Supp.2d 164 (D.Me. 2004) (ripeness and takings considerations in preliminary injunction context)
Read the full case